Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meryl E Lusher

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour CommitteeDavid W Ellison, Olabisi E Onilude, Janet C Lindsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesDavid W Ellison, Mehmet Kocak, James Dalton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Rapid diagnosis of medulloblastoma molecular subgroupsEd C Schwalbe, Janet C Lindsey, Debbie Straughton, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour CommitteeDavid W Ellison, Olabisi E Onilude, Janet C Lindsey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesDavid W Ellison, Mehmet Kocak, James Dalton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Rapid diagnosis of medulloblastoma molecular subgroupsEd C Schwalbe, Janet C Lindsey, Debbie Straughton, et al.
Acta Neuropathologica|December 6, 2011
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSarra L Ryan, Ed C Schwalbe, Michael Cole, et al.
Pageof 2